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Abstract An abundant matrix protein was purified under native conditions from adult bovine tendon and identified as cartilage oligomeric matrix 
protein (COMP) by immunochemical crossreaction, amino acid sequence identity of tryptic peptides derived from both N- and C-terminal regions, 
and structure revealed by electron microscopy. Immunohistochemistry showed age-dependent differences in distribution of COMP in tendon. 
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1. Introduction 
Tendons function to transmit the force of muscle contraction 
to bone and are composed of collagen, proteoglycans, non- 
collagenous proteins, and a relatively few cells. The major mo- 
lecular constituent is type I collagen which makes up SO-90% 
of the dry weight. The collagen molecules combine in a quarter- 
stagger arrangement into microfibrils, which are laterally 
joined into subfibrils and fibrils. This structural organization 
of the collagen molecules infers high tensile strength to the 
tissue. Proteoglycans and non-collagenous proteins in the ten- 
don matrix may serve to regulate collagen fibril size, as links 
between the collagen fibrils and/or other matrix constituents, 
and in mediating cell-matrix interactions. In areas where ten- 
dons pass over an articular joint, large compressive stresses are 
produced. These parts show a cartilage-like phenotype, includ- 
ing the expression of the large cartilage proteoglycan aggrecan 
VI. 
Cartilage oligomeric matrix protein (COMP), a pentameric 
non-collagenous glycoprotein, has recently been isolated and 
characterized in a native form from the Swarm rat chondrosar- 
coma [2] as well as from bovine [3,4] and human articular 
cartilage [5]. Sequence determination of COMP revealed it to 
be a member of the thrombospondin protein family [6]. COMP 
has been found in a variety of cartilages but could not be 
detected in a panel of extracts of other tissues when analysed 
by inhibition enzyme linked immunosorbent assay (ELISA), 
leading to the assumption that COMP is a cartilage-specitic 
matrix protein [3]. 
2. Materials and methods 
Adult bovine tendon (flexor tendons which pass over the fetlock 
joint, 200 g wet weight) was obtained fresh from the slaughterhouse. 
Tendon pieces were homogenized on ice with a Polytron homogenizer 
at full speed in (500 ml) prechilled neutral salt buffer 0.15 M NaCl, 50 
mM Tris-HCl, pH 7.4, containing the proteinase inhibitors 1 mM 
phenylmethanesulfonyl fluoride (PMSF), 2 mM N-ethyhnaleimide 
(NEM) and 0.025 mg/ml leupeptin. The homogenate was centrifuged 
for 30 min at 8,000 rpm in a Beckman JA 20 rotor at 4°C. The super- 
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natant was saved and the pellet resuspended in the same buffer by brief 
homogenization on ice. The sequential extractions were all performed 
with proteinase inhibitors and consisted of two extractions with neutral 
salt buffer and two extractions with neutral salt buffer containing, in 
addition, 10 mM EDTA. 
The first extract obtained with EDTA-containing buffer was diluted 
with an equal volume of cold distilled water and immediately applied 
to an ion exchange column of (50 x 2.6 cm) of DEAE Sepharose (Phar- 
macia) equilibrated at 4°C with 10 mM &is-HCl, pH 7.4, containing 
10 mM EDTA. 1 mM PMSF. and 2 mM NEM. After washine with 
equilibration buffer, the column was eluted with a linear gradieni from 
0 to 0.5 M NaCl (1000 ml) in the same buffer. COMP-containing 
fractions were pooled, concentrated by ultrafiltration (YM 10 filter, 
Amicon) and applied to a gel filtration column (100 x 2.6 cm) of Sepha- 
rose CL 4B (Pharmacia) eluted with 0.15 M NaCl, 50 mM Tris-HCl, 
pH 7.4, containing 2 mM EDTA, 1 mM PMSF, and 2 mM NEM. 
COMP-containing fractions were identified by SDS-PAGE, pooled, 
and further purified by separation on a Superose 6 column eluted in the 
same buffer. 
SDS-PAGE was performed according to the protocol of Laemmli [7]. 
Reduction of disulfide bonds was achieved by addition of 7 @/ml 
2-mercaptoethanol to the sample buffer. Purified bovine tendon COMP 
was submitted to SDS-PAGE under reducing conditions and electro- 
phoretically transferred to an Immobilon-PsQ membrane (Millipore). 
The band corresponding to COMP subunits was cut out, digested with 
trypsin and fragments equenced on an Applied Biosystems equencer 
after separation by microbore reversed-phase HPLC. 
Antisera against COMP, purified from bovine and human articular 
cartilage and Swarm rat chondrosarcoma, as well as an antiserum 
against bovine type I collagen, were raised in rabbits. ELISA was 
performed in plates coated with purified bovine tendon or articular 
cartilage COMP at 5 @ml. Serial dilutions of rabbit antisera to bovine, 
human, or rat COMP, and bovine type I collagen were added and 
binding detected using a secondary antibody to rabbit IgG conjugated 
with peroxidase (DAKO) and 5-amino-2-hydroxy benzoic acid as a 
substrate. Immunohistochemistry was done on chondroitinase ABC- 
treated cryosections using the antiserum to bovine COMP and a perox- 
idase-coupled second antibody [8]. 
3. Results and discussion 
An extract of bovine tendon, obtained with EDTA-contain- 
ing buffer, contained enriched amounts of a protein with simi- 
lar electrophoretic mobility and sensitivity to reduction as 
COMP (apparant molar mass 450 kDa before and 110 kDa 
after reduction), a major matrix protein of bovine articular 
cartilage. This protein was isolated by sequential ion exchange 
chromatography and gel filtration (Fig. 1). ELISA titration of 
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the purified bovine tendon protein showed strong recognition 
by antisera both to human and bovine cartilage COMP, and 
to a lesser, but significant, extent by an antiserum to Swarm rat 
chondrosarcoma COMP. The antiserum to bovine cartilage 
COMP showed the same affinity in ELBA titration to the 
tendon protein as to purified bovine cartilage COMP (Fig. 2). 
Final confirmation of the identity of tendon COMP was 
achieved by amino acid sequence analysis from one N- and two 
C-terminal tryptic fragments of tendon COMP (Fig. 3). The 
three peptide sequences of bovine tendon COMP showed 
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Fig. 1. Purification of bovine tendon COMP. The first EDTA contain- 
ing extract was applied to a DEAE-Sepharose column (A) and eluted 
with a linear gradient of O-O.5 M NaCI. COMP containing fractions 
(bar) were pooled, concentrated by ultrafiltration, and passed over a 
Sepharose CL4B molecular sieve (B). The COMP pool (bar) from the 
CL-QB chromatography was further concentrated and rechromatogra- 
phed on FPLC Superose 6 HR lo/30 (C) molecular sieve. Purified 
COMP (bar) from tendon had the same electrophoretic motility as 
COMP from both bovine articular cartilage and Swarm rat chondrosar- 
coma (not shown). 
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Fig. 2. ELISA titration of purified tendon COMP and COMP from 
bovine articular cartilage. All antibodies to cartilage COMP recognized 
tendon COMP. Antibodies to bovine cartilage COMP recognized bo- 
vine tendon COMP with the same ahinity as their original antigen. 
Polyclonal antibodies to bovine (0) articular cartilage COMP (anti- 
BAC) on bovine articular cartilage COMP; (0) anti-BAC to tendon 
COMP (T-COMP); (v) antibodies to human articlar cartilage COMP 
on T-COMP; (V) antibodies to Swarm rat chondrosarcoma COMP to 
T-COMP; (0) antibodies to type I collagen on T-COMP. 
marked homology to the corresponding sequences of rat and, 
when known, bovine COMP [6]. Electron microscopic evalua- 
tion of bovine tendon COMP revealed particles identical to 
those of bovine articular cartilage COMP [4] with five globular 
end units connected by thin flexible strands to a central domain 
(not shown). Immunostaining on cryosections of adult and fetal 
bovine tendon with antibodies to bovine cartilage COMP 
showed intense staining in the areas around the collagen fibers 
and the connective tissue surrounding the tendon bundles (Fig. 
4). In adult tendon an increased punctuate staining in the areas 
around collagen fibers was observed. 
The protein purified from tendon agreed in electrophoretic 
mobility, immunological reactivity, electron microscopic struc- 
ture, and amino acid sequence with bovine articular cartilage 
derived COMP. We therefore conclude that this tendon protein 
is identical to cartilage COMP and thus represents another 
constituent of the cartilaginous extracellular matrix, in addition 
to aggrecan, which is present in tendon. 
Tendon extracellular matrix consists predominantely of type 
I collagen, but non-collagenous proteins are present and may 
play important structural and/or functional roles. Tendons ap- 
pear to express a cartilage-like phenotype particularly when 
subjected to compressive loads [l]. The nature of the pheno- 
typic change is not well understood but believed to be due to 
either a proliferation of cartilage-like cells or a switch in syn- 
thetic expression of the tendon fibroblasts. It is probable that 
synthesis of a cartilage-like matrix provides a structural modifi- 
cation in the tendon to enable it to adapt to altered mechanical 
requirements. 
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Fragment 1: 
rat cartilage COMP 
bov. tendon COMP 
. . . - R=V-K-E-I-T-F-L-K-N-T-V=-.., 
. . . -E-l-T-F-L-K-... 
Fragment 2: 
rat cartilage COMP 
bov. cartilage COMP 
bov. tendon COMP 
. . . _S679-y_R_W_F_L..Q_H_R,p_Q_V_G_y_I_R694 _... 
. . . -s -Y-R-W-F-L-Q-H-R-P-Q-V-G-Y-l-R-... 
a.. -W-F-L-Q-H-R-G-Q-V-G-... 
Fragment 3: 
rat cartilage COMP . . . -R664-V-R-F-y-E_G_P_E_L_V_A_D_S_N_V_V_L_D_T_A714 _... 
bov. cartilage COMP . . . -R -V-R-F-Y-E-G-P-E-L-V-A-D-S-N-V-l-L-D-T-T-... 
bov. tendon COMP . . . -F-Y-E-G-P-E-L-V-A-D-X-N-V- I -L-m. 
Fig. 3. Amino acid sequence of tryptic fragments of bovine tendon COMP. The protein sequences of the three tryptic fragments for bovine tendon 
COMP are highly homologous with e corresponding cDNA-derived sequences for rat and, when available, bovine cartilage COMP. Prom8 (rat 
cartilage COMP) in the cDNA derived sequences of rat and bovine cartilage COMP was detected as Gly in the protein sequence of bovine tendon 
COMP. In the protein sequence of fragment 3 no amino acid derivative was recovered in the step corresponding to Ser”rr in the rat sequence indicating 
that this residue carries an O-linked oligosaccharide. The numbering of residues in the rat sequence includes the signal peptide. 
Fig. 4. Immunohistochemistry of fetal and adult tendon with antibodies to bovine cartilage COMP. Indirect immunoperoxidase histochemistry was 
done on cryosections of fetal (a,b) and adult (c,d) bovine tendon from the fetlock joint. The presence of COMP in the connective tissue surrounding 
tendon bundles and in a punctuate manner between the collagen fibers is clearly detected (c). The staining both around and within tendon bundles 
is seen also in fetal tendon (a), but is more diffuse. Control sections were treated with preimmune serum at the same dilution (b,d). Bar = 50 ,um. 
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